$KYMR Kymera Therapeutics, Inc. Insider Trading Week 11/2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Kymera Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Kymera Therapeutics, Inc. in week 11/2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 16 2021 | KYMR | Kymera Therapeutic ... | Booth Bruce | Director | Sell | S | 56.50 | 229,350 | 12,958,275 | 0 | 229.4 K to 0 (-100.00 %) |
| Mar 16 2021 | KYMR | Kymera Therapeutic ... | ATLAS VENTURE ASSOCIATES X, L. ... | 10% Owner | Sell | S | 56.50 | 229,350 | 12,958,275 | 0 | 229.4 K to 0 (-100.00 %) |
| Mar 16 2021 | KYMR | Kymera Therapeutic ... | Ridloff Elena | Director | Option Exercise | A | 56.10 | 40,127 | 2,251,125 | 40,127 | |
| Mar 15 2021 | KYMR | Kymera Therapeutic ... | Gollob Jared | Chief Medical Offic ... | Option Exercise | M | 1.31 | 7,800 | 10,218 | 60,007 | |
| Mar 15 2021 | KYMR | Kymera Therapeutic ... | Gollob Jared | Chief Medical Offic ... | Option Exercise | M | 1.31 | 2,200 | 2,882 | 67,807 | |
| Mar 15 2021 | KYMR | Kymera Therapeutic ... | Gollob Jared | Chief Medical Offic ... | Sell | S | 60.17 | 10,305 | 620,052 | 42,547 | 52.9 K to 42.5 K (-19.50 %) |
| Mar 15 2021 | KYMR | Kymera Therapeutic ... | Gollob Jared | Chief Medical Offic ... | Buy | M | 1.31 | 7,800 | 10,218 | 52,852 | 45.1 K to 52.9 K (+17.31 %) |
| Mar 15 2021 | KYMR | Kymera Therapeutic ... | Gollob Jared | Chief Medical Offic ... | Sell | S | 60.05 | 4,695 | 281,939 | 45,052 | 49.7 K to 45.1 K (-9.44 %) |
| Mar 15 2021 | KYMR | Kymera Therapeutic ... | Gollob Jared | Chief Medical Offic ... | Buy | M | 1.31 | 2,200 | 2,882 | 49,747 | 47.5 K to 49.7 K (+4.63 %) |
| Mar 15 2021 | KYMR | Kymera Therapeutic ... | Jacobs Bruce N. | Chief Financial Off ... | Option Exercise | M | 2.08 | 8,195 | 17,046 | 234,061 | |
| Mar 15 2021 | KYMR | Kymera Therapeutic ... | Jacobs Bruce N. | Chief Financial Off ... | Option Exercise | M | 2.08 | 1,805 | 3,754 | 242,256 | |
| Mar 15 2021 | KYMR | Kymera Therapeutic ... | Jacobs Bruce N. | Chief Financial Off ... | Sell | S | 60.17 | 8,195 | 493,096 | 0 | 8.2 K to 0 (-100.00 %) |
| Mar 15 2021 | KYMR | Kymera Therapeutic ... | Jacobs Bruce N. | Chief Financial Off ... | Buy | M | 2.08 | 8,195 | 17,046 | 8,195 | 0 to 8.2 K |
| Mar 15 2021 | KYMR | Kymera Therapeutic ... | Jacobs Bruce N. | Chief Financial Off ... | Sell | S | 60.07 | 1,805 | 108,432 | 0 | 1.8 K to 0 (-100.00 %) |
| Mar 15 2021 | KYMR | Kymera Therapeutic ... | Jacobs Bruce N. | Chief Financial Off ... | Buy | M | 2.08 | 1,805 | 3,754 | 1,805 | 0 to 1.8 K |